ProQR Therapeutics Files Prospectus For Offering 3.03M Ordinary Shares On Behalf Of Selling Shareholder

Benzinga Newsdesk www.benzinga.com Neutral 93.4%

Neg 0% Neu 93.4% Pos 0%

https://www.sec.gov/Archives/edgar/data/1612940/000110465926080750/tm2619566-1_f3.htm

Comments

No comments yet. Be the first!